黑龙江省药品监督管理局药品GMP符合性检查结果通告（2025年 第3号）

Core Points - The Heilongjiang Provincial Drug Administration announced that 14 companies, including Heilongjiang Fuhua Pharmaceutical Group Co., Ltd., passed the GMP compliance inspection as per the requirements of the Drug Administration Law and the revised Drug Production Supervision and Administration Measures [2][3] Group 1: Compliance Inspection Results - Heilongjiang Fuhua Pharmaceutical Group Co., Ltd. was inspected on February 17, 2025, for its small-volume injection production line [2] - Heilongjiang Ruige Pharmaceutical Co., Ltd. was inspected on February 7, 2025, for its solid dosage form production line [2] - Harbin Tiandi Pharmaceutical Co., Ltd. was inspected on January 8, 2025, for its solid dosage and traditional Chinese medicine extraction production lines [2] - Lantai Pharmaceutical Co., Ltd. was inspected from January 17 to 22, 2025, for its solid dosage production area [2] - Heilongjiang Hasan Pharmaceutical Co., Ltd. was inspected on February 17, 2025, for its raw material drug production line [2] Group 2: Additional Inspections - Heilongjiang Yuheng Pharmaceutical Co., Ltd. was inspected from March 4 to 6, 2025, for its oral dosage and capsule production lines [2] - Heilongjiang Bujia Tang Pharmaceutical Co., Ltd. was inspected from February 6 to 9, 2025, for its solid dosage production line [2] - Heilongjiang Songhua River Pharmaceutical Technology Co., Ltd. was inspected from February 13 to 16, 2025, for its freeze-dried powder injection and extraction production lines [3] - Heilongjiang Tianlong Pharmaceutical Co., Ltd. was inspected from September 26 to 29, 2024, for its eye drop production line [3] - Heilongjiang Jinjiao Pharmaceutical Co., Ltd. was inspected on February 13, 2025, for its small-volume injection production line [3]